Cuba’s BioCubaFarma group is expected to increase the production of a drug called Interferon B which cures the novel coronavirus, COVID-19, pharmaceutical executives announced Friday.
BioCubaFarma President Eduardo Martinez said they have developed 22 drugs, including Interferon B, that are set to be used to contain the COVID-19 global pandemic.
The company reports 1,500 COVID-19 patients having been cured by taking Interferon B and the drug will be used by the Chinese National Health Commission to combat the disease which attacks the respiratory system.
Mr. Martinez said the drug could be exported to other countries to help contain the spread of the virus and treat those that are showing symptoms.
Interferon B was first developed in 1986 by a team of researchers from the Centre for Genetic Engineering and Biotechnology (CIGB) and introduced into the Cuban health system. Interferon is described as “the flagship product of the set of Cuban medicines” being developed by both Cuba and China in a joint venture.
Source: The Haiti Sentinel | Cuba rolls out first coronavirus-fighting drug in China
Leave a Reply